2015 | HFSA

2015 Call for Abstracts

Practice News

2015 Complete Call For Abstracts

Call for Abstracts Deadline: April 9, 2015 (Thursday 11:59 PM CT)

Click Here To Access The Abstract Submission Website

The 19TH Annual Scientific Meeting will once again feature:

  • Posters
  • Rapid-Fire Abstract Sessions
  • Oral Abstract Award Sessions

YOUTUBE PRESENTATION ON ABSTRACT & POSTER PREPARATION

A YouTube Presentation has been prepared with detailed advice on abstract and poster preparation, including expert tips and specific examples. All authors will benefit, particularly those who are relatively new to abstract submission.

Watch the presentation (Playing time: 28 min.)

POSTER DISPLAYS

Posters and oral abstract presentations are an important part of the HFSA Annual Scientific Meeting. Accepted abstracts will be displayed as posters in a designated section of the Exhibit Hall on Saturday-Monday, September 26-28, 2015. Award sessions and Rapid-fire Abstract sessions are included in the scientific program. Abstracts on heart failure research are invited in the following categories:

  • Cardiovascular Pharmacology
  • Cardiovascular Physiology
  • Cardiovascular Structure / Imaging
  • Clinical Care
  • Clinical Trials
  • Electrophysiology / Arrhythmias
  • Epidemiology / Prevention
  • Molecular Biology / Genetics / Cell Therapy
  • Biomarkers / Neurohormones / Cytokines
  • Quality of Care / Outcomes
  • Surgery / Transplantation / Devices
  • Management Strategies / Adherence / Self Care

INVESTIGATOR AWARDS

HFSA offers 3 award competitions at its annual meeting:

  • Jay N. Cohn New Investigator Award - Basic Science
  • Jay N. Cohn New Investigator Award - Clinical/Integrative Physiology
  • Nursing Investigator Award

These awards are to recognize research excellence in young trainees and investigators. Finalists will present their work orally in scientific sessions.

Jay N. Cohn New Investigator Awards

A review committee will choose up to five finalists in each of two categories:

  • Basic science
  • Clinical/integrative physiology research

Eligibility: Candidates must have completed training no earlier than 2012, be first author and have played a major role in research study being submitted. The finalist must present their research results in respective JNCNI award sessions during the 19th Annual Scientific Meeting.

Nursing Investigator Award

This award recognizes outstanding and innovative research in the field of heart failure by a nurse researcher. Up to 5 finalists are chosen.

Eligibility: Candidate must be a nurse investigator or a student in an accredited nursing program and first author and presenter of the abstract submitted. Candidate cannot be a member of the HFSA Nursing Award Committee. Previous finalists for this award are ineligible. Individuals cannot apply for both the Clinical Excellence in Nursing and Nursing Research Awards in the same year.

Award Notification

Award finalists will be notified on or about June 8, 2015. Monetary awards are provided to first and second place presenters. All award finalists receive complimentary registration.

TRAVEL GRANTS

Travel grants up to $1,500 are available for medical fellows* whose abstracts are accepted for oral or poster presentation at the Annual Meeting. Go to the 2015 Travel Grant Page for more information and an application form.

*Support provided by Medtronic, Inc.

RAPID-FIRE ABSTRACTS

Abstracts of special interest will be selected for oral presentation with slides and audience comment in one of two Rapid-Fire Abstract sessions on Sunday and Monday. Presentations are 3 minutes, followed by 2 minutes of questions and discussion. Details will be included with the abstract acceptance letter.

Award abstracts and abstracts accepted for rapid-fire oral presentations will be displayed as featured posters, as well.

ABSTRACT SUBMISSION PROCESS

Electronic Submission

The submission site works optimally with Microsoft Internet Explorer version 7.0 or higher, Safari version 4.0 or higher, or Mozilla Firefox version 6.0 or higher. The Call for Abstracts screen provides links to this free software.

The site is available 24 hours a day. Multiple authors can easily review or work on the abstract from different locations. The site supports graphic images, tables (with special characters/symbols), Greek characters and special symbols.

If technical assistance is needed, contact Coe Truman Abstract Management at (507) 403-2305. Technical support is available Monday-Friday 8:00 AM to 5:00 PM CT.

Click Here To Access The Abstract Submission Website

Abstract Deadline

Abstracts must be received electronically no later than 11:59 PM (CT), Thursday, April 9, 2015. Paper submissions or faxed abstracts will not be accepted. An email will confirm that the abstract has been received.

Acceptance

  1. All abstracts submitted must comply with the guidelines to be considered for acceptance.
  2. Abstract grading is blinded. Abstracts are selected on the basis of scientific merit.
  3. Acceptance notifications will be sent on or about June 1, 2015.
  4. Authors will be expected to attend the meeting and present their posters.
  5. Abstracts accepted are embargoed for release until the time of presentation at the Heart Failure Society of America's Scientific Meeting.
  6. Abstracts accepted for presentation will be published as a supplement to the Journal of Cardiac Failure. Authors whose abstracts are accepted give HFSA permission and authority to submit and publish their abstract, without compensation, in the Journal of Cardiac Failure.

Abstracts selected for oral presentation in an award session or a Rapid-Fire session will receive special notification letters with additional information.

ABSTRACT SUBMISSION GUIDELINES

Author Names

  1. If an author's name appears on more than one abstract, it must be identical on each abstract.
  2. The submitting author is designated as the presenting or primary author. The senior author must be listed last.

Abstract Data

  1. The Heart Failure Society of America is a forum for presentation of novel research findings. Therefore, work covered by the abstract must not have been published as a manuscript or abstract prior to March 31, 2015.
  2. Abstract data may not be presented at a national meeting or world congress in the United States prior to July 1, 2015.
  3. Data should not be "split" to create several abstracts from one. Splitting will result in reduced scores for related abstracts.
  4. Abstracts containing identical or nearly identical data submitted from the same institution or individual will be disqualified.
  5. Informed consent: any studies involving human subjects must conform to the principles of the Declaration of Helsinki of the World Medical Association (Clinical Research 1996;14:103) and must meet all of the requirements governing informed consent of the country in which the study was performed. Any procedures performed must meet with prevailing ethical standards.
  6. Use of Animals: All studies involving the use of animals must conform with the 1991 revision of "Guiding Principles in the Care and Use of Animals" (American Physiological Association).

Abstract Submissions by Industry

Abstract submissions from industry are allowed. Submissions must focus on science and research, not on specific products or services. Abstract presentations cannot be sales presentations or endorsements for products or services.

Abstract Withdrawal

Withdrawal of accepted abstracts must be received in writing by HFSA no later than June 15, 2015 to avoid publication in the Journal of Cardiac Failure supplement.

Abstracts submitted to HFSA and AHA

The American Heart Association has modified their policy regarding abstracts accepted for presentation at the 2015 AHA Scientific Sessions and other scientific meetings including the HFSA. This is for early career Investigators only. “If early career investigators feel compelled to increase their opportunity of scientific interaction, then the abstract submission to the AHA must have incremental information from the abstract submitted elsewhere to justify submission and presentation at the AHA, should the investigator’s work be accepted at both meetings. Each investigator will determine, in good conscience, what constitutes incremental information and should notify AHA staff.”

Guidelines for Abstract Submission

Title

An abstract must have a short, specific title (no abbreviations) that clearly indicates the nature of the investigation. Make the title dynamic and conclusive, rather than descriptive.

Text

  1. Briefly describe the objectives of the study unless they are contained in the title. If applicable, include a brief statement of methods. State findings in sufficient detail to support conclusions. Abstracts should not describe research in which the chemical identity or source of the reagent is proprietary or cannot be revealed.
  2. Use generic names wherever possible. Use trade names only when necessary.
  3. Avoid beginning sentences with numerals.
  4. Standard abbreviations may be used without definition. Nonstandard abbreviations should be placed in parentheses after the first use of the word or phrase abbreviated.
  5. No references, credits or grant support should be included in the abstract.
  6. No identifying information about patients participating in a study or trial should be used.
  7. Proofread abstracts carefully to avoid errors before submission. No corrections will be allowed or made once abstract has been submitted.

Writing an Abstract

  1. Title: Make the title dynamic and conclusive, rather than descriptive
  2. Structure: A well-written abstract typically has the following identified sections: Introduction, Hypothesis, Methods, Results and Conclusions.
  3. Category: Check submission category carefully to assure proper consideration.
  4. Length: Maximum length is 2800 characters, including tables and graphs.

Award Competitions

If submitting for an award competition, please check the appropriate box and provide required information. Abstracts submitted for award competition cannot be submitted as Poster Presentation Only.

Co-Author Approval

The submitting author must verify that all co-authors have read and approved the abstract submission.

Disclosure Form

A disclosure form identifying commercial relationships for all co-authors must be completed online by the submitting author. When the box has been checked, the submitting author is signing and verifying disclosure on behalf of all co-authors. Disclosure information for accepted abstracts will be made available to the 2015 scientific meeting attendees.

ABOUT HFSA

The Heart Failure Society of America (HFSA) represents the first organized effort by heart failure experts from the Americas to provide a forum for all those interested in heart failure research and patient care. The HFSA is dedicated to:

  • Promoting research related to all aspects of heart failure and to providing a forum for presentation of basic, clinical and population-based research.
  • Educating health care professionals through programs, publications, and other media in the areas of basic science, clinical medicine, patient management, and social, ethical and economic issues to enable them to diagnose and treat heart failure and concomitant medical conditions more effectively.
  • Encouraging primary and secondary preventive measures to reduce the incidence of heart failure; serving as a resource for government, private industry, and health care providers to facilitate the establishment of programs and policies that will better serve the patient.
  • Enhancing quality and duration of life in those with heart failure.
  • Promoting and facilitating the formal training of physicians, scientists and allied health care providers in the field of heart failure.

Officers

JoAnn Lindenfeld, MD (President)
Mandeep R. Mehra, MD (Vice President)
Christopher O’Connor, MD (Treasurer)
Sara C. Paul DNP, FNP (Secretary)

Membership Information

Membership in the Society is open to all health care professionals with an interest in cardiovascular medicine. For information about the HFSA and how to become a member, visit the HFSA web site: www.hfsa.org.

Visas / Letters of Invitation

Attendees with visa requirements should begin the process early. Letters of invitation for visa purposes will be provided upon request. Letters of invitation are provided to help attendees obtain visas, not as commitments to provide financial support. Decisions to grant visas belong solely to embassies and consulates. When applications are denied, HFSA cannot change the decision of a government agency. Requests should be sent to [email protected].

Special Needs

HFSA strives to hold meetings accessible to all. Please let us know about special requirements. Please contact Nikki Ahmetaj, Global Meetings & Incentives at [email protected] at (908) 358-3082.

Questions

Heart Failure Society of America (HFSA)
6707 Democracy Blvd. Suite 925 | Bethesda, MD 20817

Phone: (301) 312-8635

Fax: 301.968.2431

E-mail: HFSA Information